Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Trials Underestimate Age of Chronic Myeloid Leukemia (CML) Patients: Epidemiological Study in a Representative Area in Germany.

M. Rohrbacher, U. Berger, A. Hochhaus, G. Metzgeroth, K. Adam, T. Lahaye, S. Saussele, J. Hasford, H. Heimpel, Rüdiger Hehlmann

Blood (2007) 110 (11): 2955.

https://doi.org/10.1182/blood.V110.11.2955.2955

Published: 2007

Journal Articles

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

J Hasford, M Baccarani, R Hehlmann, H Anseri, S Tura, E Zuffa

Blood (1996) 87 (12): 5384–5391.

https://doi.org/10.1182/blood.V87.12.5384.bloodjournal87125384

Published: 1996

Journal Articles

Randomized Comparison of Interferon-{alpha}, Hydroxyurea, and Busulfan in Chronic Myeloid Leukemia: Response to Kantarjian and Talpaz and to Tura and Baccarani

R. Hehlmann, H. Heimpel, J. Hasford

Blood (1995) 85 (10): 3000–3002.

https://doi.org/10.1182/blood.V85.10.3000.bloodjournal85103000

Published: 1995

Journal Articles

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, A Hochhaus, B Heinze

Blood (1994) 84 (12): 4064–4077.

https://doi.org/10.1182/blood.V84.12.4064.bloodjournal84124064

Published: 1994

Journal Articles

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group

R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, B Heinze, A Georgii

Blood (1993) 82 (2): 398–407.

https://doi.org/10.1182/blood.V82.2.398.398

Published: 1993

NARROW

Clinical Trials Underestimate Age of Chronic Myeloid Leukemia (CML) Patients: Epidemiological Study in a Representative Area in Germany.

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

Randomized Comparison of Interferon-{alpha}, Hydroxyurea, and Busulfan in Chronic Myeloid Leukemia: Response to Kantarjian and Talpaz and to Tura and Baccarani

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group

Email alerts

ASH Publications

American Society of Hematology

Clinical Trials Underestimate Age of Chronic Myeloid Leukemia (CML) Patients: Epidemiological Study in a Representative Area in Germany.

Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha [letter]

Randomized Comparison of Interferon-{alpha}, Hydroxyurea, and Busulfan in Chronic Myeloid Leukemia: Response to Kantarjian and Talpaz and to Tura and Baccarani

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only